loading page

Case Series: Stenotrophomonas maltophilia in Pediatric Oncology Patients
  • +3
  • Sanila Sarkar,
  • Lea Stitzlein,
  • Emily Rav,
  • Shehla Razvi,
  • Michael Chang,
  • Ramia Zakhour
Sanila Sarkar
The University of Texas MD Anderson Cancer Center Children's Cancer Hospital

Corresponding Author:[email protected]

Author Profile
Lea Stitzlein
The University of Texas MD Anderson Cancer Center Children's Cancer Hospital
Author Profile
Emily Rav
The University of Texas MD Anderson Cancer Center Children's Cancer Hospital
Author Profile
Shehla Razvi
The University of Texas MD Anderson Cancer Center Children's Cancer Hospital
Author Profile
Michael Chang
The University of Texas Health Science Center at Houston Department of Pediatrics
Author Profile
Ramia Zakhour
The University of Texas Health Science Center at Houston Department of Pediatrics
Author Profile

Abstract

Stenotrophomonas maltophilia is a bacterial pathogen that can be fatal in hospitalized and immunocompromised patients with mortality as high as 69%. Risk factors for infection include those apparent in many pediatric cancer patients. Treatment is challenging as S. maltophilia is resistant to several antibiotics. Furthermore, the presentation of soft tissue infection in neutropenic patients may be atypical. We present three immunocompromised pediatric patients with S. maltophilia infections. All three cases were fatal. We hope our experience at MD Anderson can guide providers to diagnose and properly treat Stenotrophomonas infection, as timely treatment may improve morbidity and mortality.